Dulaglutide (Trulicity, GLP-1 receptor agonist)-Therapeutic peptides (hIgG4 Fc fusion) drug benchmark for in-vivo/in-vitro study

Cat No.: GMP-Bios-peptide-002

Product Name: Dulaglutide

Structural formula:

Picture loading failed.
Picture loading failed.

Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

Order information

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-peptide-002-1mg 1mg 3090
GMP-Bios-peptide-002-10mg 10mg 21890
GMP-Bios-peptide-002-100mg 100mg 148000
GMP-Bios-peptide-002-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Product NameDulaglutide
Brand nameTrulicity
CAS No.923950-08-7
Resource (expression host)mammalian
Specics/IsotypesRecombinant protein fused to an Fc fragment of human IgG4
Biological ActivityDulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4.
PurityPurity: ≥95% (SDS-PAGE)
ApplicationTherapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development.
Predicted Molecular Mass3213.2
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.